Top

Published in:

01-11-2018 | Review

PA-X: a key regulator of influenza A virus pathogenicity and host immune responses

Authors: Jiao Hu, Chunxi Ma, Xiufan Liu

Published in: Medical Microbiology and Immunology | Issue 5-6/2018

Abstract

PA-X, a fusion protein belonging to influenza A viruses (IAVs), integrating the N-terminal 191 amino acids of PA gene and the ribosomal frame-shifting product that lengthens out to 41 or 61 amino acids. Since its discovery in 2012, multiple functions have been attributed to this small protein, including a process, where wide-spread protein synthesis in infected host cells is shut down (called host shutoff), and viral replication, polymerase activity, viral-induced cell apoptosis, PA nuclear localization, and virulence are modulated. However, many of its proposed functions may be specific to strain, subtype, host, or cell line. In this review, we start by describing the well-defined global host-shutoff ability of PA-X and the potential mechanisms underlying it. We move on to the role played by PA-X in modulating innate and acquired immune responses in the host. We then systematically discuss the role played by PA-X in modulating the virulence of influenza viruses of different subtypes and host origins, and finish with a general overview of the research advances made in identifying the host cell partners that interact with PA-X. To uncover possible clues about the differential effects of PA-X in modulating viral virulence, we focus on systemically evaluating polymorphisms in PA-X from various viral subtypes and hosts, including avian and human H5N1, H5N6, H9N2, and H7N9 viruses. Finally, we conclude with a proposition regarding the possible future research directions for this important protein.

Shindo N, Briand S (2012) Influenza at the beginning of the 21st century. B World Health Organ 90(4):247–247. https://doi.org/10.2471/Blt.12.104653 CrossRef

Cinatl J, Michaelis M, Doerr HW (2007) The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants. Med Microbiol Immun 196(4):181–190. https://doi.org/10.1007/s00430-007-0042-5 CrossRef

Horimoto T, Kawaoka Y (2005) Influenza: Lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3(8):591–600. https://doi.org/10.1038/nrmicro1208 CrossRefPubMed

Taubenberger JK, Reid AH, Lourens RM, Wang RX, Jin GZ, Fanning TG (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437(7060):889–893. https://doi.org/10.1038/nature04230 CrossRefPubMed

Yoon SW, Webby RJ, Webster RG (2014) Evolution and ecology of influenza A viruses. Influenza Pathog Control 385:359–375. https://doi.org/10.1007/82_2014_396 CrossRef

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu XY, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RAM, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Boxrud D, Sambol AR, Abid SH, George KS, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325(5937):197–201. https://doi.org/10.1126/science.1176225 CrossRefPubMedPubMedCentral

Michaelis M, Doerr HW, Cinatl J (2009) Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immun 198(3):175–183. https://doi.org/10.1007/s00430-009-0118-5 CrossRef

Wu AP, Su CH, Wang DY, Peng YS, Liu M, Hua S, Li TX, Gao GF, Tang H, Chen JZ, Liu XF, Shu YL, Peng DX, Jiang TJ (2013) Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe 14(4):446–452. https://doi.org/10.1016/j.chom.2013.09.001 CrossRefPubMed

Chen WS, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O’Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7(12):1306–1312. doi:https://doi.org/10.1038/Nm1201-1306 CrossRefPubMed

10.

Wise HM, Foeglein A, Sun JC, Dalton RM, Patel S, Howard W, Anderson EC, Barclay WS, Digard P (2009) A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83(16):8021–8031. https://doi.org/10.1128/Jvi.00826-09 CrossRefPubMedPubMedCentral

11.

Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger JK, Digard P (2012) An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337(6091):199–204. https://doi.org/10.1126/science.1222213 CrossRefPubMedPubMedCentral

12.

Wise HM, Hutchinson EC, Jagger BW, Stuart AD, Kang ZH, Robb N, Schwartzman LM, Kash JC, Fodor E, Firth AE, Gog JR, Taubenberger JK, Digard P (2012) Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. Plos Pathog. https://doi.org/10.1371/journal.ppat.1002998 CrossRefPubMedPubMedCentral

13.

Selman M, Dankar SK, Forbes NE, Jia JJ, Brown EG (2012) Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing. Emerg Microb Infec. https://doi.org/10.1038/emi.2012.38 CrossRef

14.

Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y (2013) Identification of novel influenza A virus proteins translated from PA mRNA. J Virol 87(5):2455–2462. https://doi.org/10.1128/Jvi.02656-12 CrossRefPubMedPubMedCentral

15.

Shi M, Jagger BW, Wise HM, Digard P, Holmes EC, Taubenberger JK (2012) Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus. J Virol 86(22):12411–12413. https://doi.org/10.1128/Jvi.01677-12 CrossRefPubMedPubMedCentral

16.

DeDiego ML, Nogales A, Lambert-Emo K, Martinez-Sobrido L, Topham DJ (2016) NS1 protein mutation I64T affects interferon responses and virulence of circulating H3N2 human influenza A viruses. J Virol 90(21):9693–9711. https://doi.org/10.1128/JVI.01039-16 CrossRefPubMedPubMedCentral

17.

Ayllon J, Domingues P, Rajsbaum R, Miorin L, Schmolke M, Hale BG, Garca-Sastre A (2014) A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J Virol 88(20):12146–12151. https://doi.org/10.1128/Jvi.01567-14 CrossRefPubMedPubMedCentral

18.

Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol Cell 1(7):991–1000CrossRefPubMed

19.

Twu KY, Noah DL, Rao P, Kuo RL, Krug RM (2006) The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J Virol 80(8):3957–3965. https://doi.org/10.1128/Jvi.80.8.3957-3965.2006 CrossRefPubMedPubMedCentral

20.

Rodriguez A, Perez-Gonzalez A, Nieto A (2007) Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J Virol 81(10):5315–5324. https://doi.org/10.1128/Jvi.02129-06 CrossRefPubMedPubMedCentral

21.

Vreede FT, Chan AY, Sharps J, Fodor E (2010) Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells. Virology 396(1):125–134. https://doi.org/10.1016/j.virol.2009.10.003 CrossRefPubMed

22.

Llompart CM, Nieto A, Rodriguez-Frandsen A (2014) Specific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in mice. J Virol 88(6):3455–3463. https://doi.org/10.1128/Jvi.02263-13 CrossRefPubMedPubMedCentral

23.

Desmet EA, Bussey KA, Stone R, Takimoto T (2013) Identification of the N-terminal domain of the influenza virus PA responsible for the suppression of host protein synthesis. J Virol 87(6):3108–3118. https://doi.org/10.1128/Jvi.02826-12 CrossRefPubMedPubMedCentral

24.

Hu J, Mo YQ, Wang XQ, Gu M, Hu ZL, Zhong L, Wu QW, Hao XL, Hu SL, Liu WB, Liu HM, Liu XW, Liu XF (2015) PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response. J Virol 89(8):4126–4142. https://doi.org/10.1128/Jvi.02132-14 CrossRefPubMedPubMedCentral

25.

Hayashi T, Chaimayo C, Takimoto T (2015) Impact of influenza PA-X on host response. Oncotarget 6(23):19364–19365CrossRefPubMedPubMedCentral

26.

Oishi K, Yamayoshi S, Kawaoka Y (2015) Mapping of a region of the PA-X protein of influenza A virus that is important for its shutoff activity. J Virol 89(16):8661–8665. https://doi.org/10.1128/Jvi.01132-15 CrossRefPubMedPubMedCentral

27.

Hayashi T, Chaimayo C, McGuinness J, Takimoto T (2016) Critical role of the PA-X C-terminal domain of influenza A virus in its subcellular localization and shutoff activity. J Virol 90(16):7131–7141. https://doi.org/10.1128/Jvi.00954-16 CrossRefPubMedPubMedCentral

28.

Khaperskyy DA, McCormick C (2015) Timing is everything: coordinated control of host shutoff by influenza A virus NS1 and PA-X proteins. J Virol 89(13):6528–6531. https://doi.org/10.1128/Jvi.00386-15 CrossRefPubMedPubMedCentral

29.

Khaperskyy DA, Schmaling S, Larkins-Ford J, McCormick C, Gaglia MM (2016) Selective degradation of host RNA polymerase II transcripts by influenza A virus PA-X host shutoff protein. Plos Pathog 12 (2). https://doi.org/10.1371/journal.ppat.1005427 CrossRefPubMedPubMedCentral

30.

Khaperskyy DA, Emara MM, Johnston BP, Anderson P, Hatchette TF, McCormick C (2014) Influenza A virus host shutoff disables antiviral stress-induced translation arrest. Plos Pathog. https://doi.org/10.1371/journal.ppat.1004217 CrossRefPubMedPubMedCentral

31.

Nogales A, Rodriguez L, DeDiego ML, Topham DJ, Martinez-Sobrido L (2017) Interplay of PA-X and NS1 Proteins in replication and pathogenesis of a temperature-sensitive 2009 pandemic H1N1 influenza A virus. J Virol. https://doi.org/10.1128/JVI.00720-17 CrossRefPubMedPubMedCentral

32.

Gao HJ, Sun HL, Hu J, Wang JL, Xiong X, Wang Y, He QM, Lin Y, Kong WL, Seng LG, Pu J, Chang KC, Liu XF, Liu JH, Sun YP (2015) Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. J Gen Virol 96:2036–2049. https://doi.org/10.1099/vir.0.000143 CrossRefPubMedPubMedCentral

33.

Hayashi T, MacDonald LA, Takimoto T (2015) Influenza A virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J Virol 89(12):6442–6452. https://doi.org/10.1128/Jvi.00319-15 CrossRefPubMedPubMedCentral

34.

Leea JW, Yua H, Li YH, Ma JJ, Lang YE, Duff M, Henningson J, Liu QF, Li YH, Nagy A, Bawa B, Li ZJ, Tong GG, Richt JE, Ma WJ (2017) Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses. Virology 504:25–35. https://doi.org/10.1016/j.virol.2017.01.015 CrossRef

35.

Gao HJ, Xu GL, Sun YP, Qi L, Wang JL, Kong WL, Sun HL, Pu J, Chang KC, Liu JH (2015) PA-X is a virulence factor in avian H9N2 influenza virus. J Gen Virol 96:2587–2594. https://doi.org/10.1099/jgv.0.000232 CrossRefPubMed

36.

Gao HJ, Sun YP, Hu J, Qi L, Wang JL, Xiong X, Wang Y, He QM, Lin Y, Kong WL, Seng LG, Sun HL, Pu J, Chang KC, Liu XF, Liu JH (2015) The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses. Sci Rep-UK. https://doi.org/10.1038/Srep08262 CrossRef

37.

Feng KH, Sun M, Iketani S, Holmes EC, Parrish CR (2016) Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression. Virology 496:138–146. https://doi.org/10.1016/j.virol.2016.06.001 CrossRefPubMed

38.

Xu GL, Zhang XX, Sun YP, Liu QF, Sun HL, Xiong X, Jiang M, He QM, Wang Y, Pu J, Guo X, Yang HC, Liu JH (2016) Truncation of C-terminal 20 amino acids in PA-X contributes to adaptation of swine influenza virus in pigs. Sci Rep-Uk. https://doi.org/10.1038/Srep21845 CrossRef

39.

Xu GL, Zhang XX, Liu QF, Bing GX, Hu Z, Sun HL, Xiong X, Jiang M, He QM, Wang Y, Pu J, Guo X, Yang HC, Liu JH, Sun YP (2017) PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine. Virology 508:45–53. https://doi.org/10.1016/j.virol.2017.05.002 CrossRefPubMed

40.

Dias A, Bouvier D, Crepin T, McCarthy AA, Hart DJ, Baudin F, Cusack S, Ruigrok RWH (2009) The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458(7240):914–918. https://doi.org/10.1038/nature07745 CrossRefPubMed

41.

Yuan PW, Bartlam M, Lou ZY, Chen SD, Zhou J, He XJ, Lv ZY, Ge RW, Li XM, Deng T, Fodor E, Rao ZH, Liu YF (2009) Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 458(7240):909–912. https://doi.org/10.1038/nature07720 CrossRefPubMed

42.

Bavagnoli L, Cucuzza S, Campanini G, Rovida F, Paolucci S, Baldanti F, Maga G (2015) The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. Nucleic Acids Res 43(19):9405–9417. https://doi.org/10.1093/nar/gkv926 CrossRefPubMedPubMedCentral

43.

Oishi K, Yamayoshi S, Kawaoka Y (2018) Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast. Virology 516:71–75. https://doi.org/10.1016/j.virol.2018.01.004 CrossRefPubMed

44.

Kwong AD, Frenkel N (1987) Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc Natl Acad Sci USA 84(7):1926–1930CrossRefPubMedPubMedCentral

45.

Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, Ito N, Kubo H, Makino S (2006) Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci USA 103(34):12885–12890. https://doi.org/10.1073/pnas.0603144103 CrossRefPubMedPubMedCentral

46.

Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, Garcia-Sastre A, Swayne DE, Katze MG (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443(7111):578–581. https://doi.org/10.1038/nature05181 CrossRefPubMedPubMedCentral

47.

Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74(17):7989–7996. doi:https://doi.org/10.1128/Jvi.74.17.7989-7996.2000 CrossRefPubMedPubMedCentral

48.

Noah DL, Twu KY, Krug RM (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3 ’ end processing of cellular pre-mRNAS. Virology 307(2):386–395. https://doi.org/10.1016/S0042-6822(02)00127-7 CrossRefPubMed

49.

Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Sousa CRE (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5 ‘-phosphates. Science 314(5801):997–1001. https://doi.org/10.1126/science.1132998 CrossRefPubMed

50.

Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T (2007) IFN beta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9(4):930–938. https://doi.org/10.1111/j.1462-5822.2006.00841.x CrossRefPubMed

51.

Wang XY, Li M, Zheng HY, Muster T, Palese P, Beg AA, Garcia-Sastre A (2000) Influenza A virus NS1 protein prevents activation of NF-kappa B and induction of alpha/beta interferon. J Virol 74(24):11566–11573. https://doi.org/10.1128/Jvi.74.24.11566-11573.2000 CrossRefPubMedPubMedCentral

52.

Gao S, Peng H, Jiang W, Song L (2010) NS1 protein of avian influenza A virus prevents activation of NF-kappa B through binding to IKK alpha and IKK beta. Int J Infect Dis 14:E82–E83. https://doi.org/10.1016/j.ijid.2010.02.1672 CrossRef

53.

Ludwig S, Wang XY, Ehrhardt C, Zheng HY, Donelan N, Planz O, Pleschka S, Garcia-Sastre A, Heins G, Wolff T (2002) The influenza A virus NS1 protein inhibits activation of jun N-terminal kinase and AP-1 transcription factors. J Virol 76(21):11166–11171. https://doi.org/10.1128/Jvi.76.21.11166-11171.2002 CrossRefPubMedPubMedCentral

54.

Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, Goodbourn S, Barclay W (2006) Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347(1):52–64. https://doi.org/10.1016/j.virol.2005.11.024 CrossRefPubMed

55.

Kochs G, Garcia-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81(13):7011–7021. https://doi.org/10.1128/Jvi.02581-07 CrossRefPubMedPubMedCentral

56.

Kuo RL, Zhao C, Malur M, Krug RM (2010) Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-beta transcription. Virology 408(2):146–158. https://doi.org/10.1016/j.virol.2010.09.012 CrossRefPubMed

57.

Li YZ, Chen ZY, Wang WR, Baker CC, Krug RM (2001) The 3 ‘-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. Rna 7(6):920–931. https://doi.org/10.1017/S1355838201010226 CrossRefPubMedPubMedCentral

58.

Das K, Ma LC, Xiao R, Radvansky B, Aramini J, Zhao L, Marklund J, Kuo RL, Twu KY, Arnold E, Krug RM, Montelione GT (2008) Structural basis for suppression of a host antiviral response by influenza A virus. P Natl Acad Sci USA 105(35):13093–13098. https://doi.org/10.1073/pnas.0805213105 CrossRef

59.

Aramini JM, Ma LC, Zhou LG, Schauder CM, Hamilton K, Amer BR, Mack TR, Lee HW, Ciccosanti CT, Zhao L, Xiao R, Krug RM, Montelione GT (2011) Dimer interface of the effector domain of non-structural protein 1 from influenza A virus an interface with multiple functions. J Biol Chem 286(29):26050–26060. https://doi.org/10.1074/jbc.M111.248765 CrossRefPubMedPubMedCentral

60.

Hatada E, Fukuda R (1992) Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73(Pt 12):3325–3329. https://doi.org/10.1099/0022-1317-73-12-3325 CrossRefPubMed

61.

Lu Y, Wambach M, Katze MG, Krug RM (1995) Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214(1):222–228CrossRefPubMed

62.

Min JY, Krug RM (2006) The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2 ‘-5 ’ oligo (A) synthetase/RNase L pathway. P Natl Acad Sci USA 103(18):7100–7105. https://doi.org/10.1073/pnas.0602184103 CrossRef

63.

Min JY, Li SD, Sen GC, Krug RM (2007) A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363(1):236–243. https://doi.org/10.1016/j.virol.2007.01.038 CrossRefPubMed

64.

Li S, Min JY, Krug RM, Sen GC (2006) Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349(1):13–21. https://doi.org/10.1016/j.virol.2006.01.005 CrossRefPubMed

65.

Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, Palese P (2011) The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon at the Level of the MAVS Adaptor Protein. Plos Pathogens. https://doi.org/10.1371/journal.ppat.1002067 CrossRefPubMedPubMedCentral

66.

Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, Wixler V, Ludwig S (2011) The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 392(12):1135–1144. https://doi.org/10.1515/Bc-2011-174 CrossRefPubMed

67.

McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA (2010) PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6(7):e1001014. https://doi.org/10.1371/journal.ppat.1001014 CrossRefPubMedPubMedCentral

68.

Le Goffic R, Leymarie O, Chevalier C, Rebours E, Da Costa B, Vidic J, Descamps D, Sallenave JM, Rauch M, Samson M, Delmas B (2011) Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein. Plos Pathog. https://doi.org/10.1371/journal.ppat.1002202 CrossRefPubMedPubMedCentral

69.

Alymova IV, Green AM, van de Velde N, McAuley JL, Boyd KL, Ghoneim HE, McCullers JA (2011) Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. J Virol 85(23):12324–12333. https://doi.org/10.1128/Jvi.05872-11 CrossRefPubMedPubMedCentral

70.

Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S, Delmas B (2010) Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J Immunol 185(8):4812–4823. https://doi.org/10.4049/jimmunol.0903952 CrossRefPubMed

71.

Krumbholz A, Philipps A, Oehring H, Schwarzer K, Eitner A, Wutzler P, Zell R (2011) Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol 200(2):69–75. https://doi.org/10.1007/s00430-010-0176-8 CrossRefPubMed

72.

Plotch SJ, Bouloy M, Ulmanen I, Krug RM (1981) A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23(3):847–858CrossRefPubMed

73.

Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, Subbarao K, Fodor E (2010) The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 84(17):8433–8445. https://doi.org/10.1128/Jvi.00879-10 CrossRefPubMedPubMedCentral

74.

Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T (2010) Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 285(42):32064–32074. https://doi.org/10.1074/jbc.M110.112458 CrossRefPubMedPubMedCentral

75.

Liedmann S, Hrincius ER, Anhlan D, McCullers JA, Ludwig S, Ehrhardt C (2014) New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variant. J Infect Dis 209(4):532–541. https://doi.org/10.1093/infdis/jit463 CrossRefPubMed

76.

Sakabe S, Takano R, Nagamura-Inoue T, Yamashita N, Nidom CA, Mai TQL, Iwatsuki-Horimoto K, Kawaoka Y (2013) Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis 207(2):262–271. https://doi.org/10.1093/infdis/jis523 CrossRefPubMed

77.

Hu J, Hu ZL, Song QQ, Gu M, Liu XW, Wang XQ, Hu SL, Chen CY, Liu HM, Liu WB, Chen SJ, Peng DX, Liu XF (2013) The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice. J Virol 87(5):2660–2672. https://doi.org/10.1128/Jvi.02891-12 CrossRefPubMedPubMedCentral

78.

Huang CH, Chen CJ, Yen CT, Yu CP, Huang PN, Kuo RL, Lin SJ, Chang CK, Shih SR (2013) Caspase-1 deficient mice are more susceptible to influenza A virus infection with PA variation. J Infect Dis 208(11):1898–1905. https://doi.org/10.1093/infdis/jit381 CrossRefPubMed

79.

Ichinohe T, Pang IK, Iwasaki A (2010) Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol 11(5):404–461. https://doi.org/10.1038/ni.1861 CrossRefPubMedPubMedCentral

80.

Talon J, Salvatore M, O’Neill RE, Nakaya Y, Zheng HY, Muster T, Garcia-Sastre A, Palese P (2000) Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. P Natl Acad Sci USA 97(8):4309–4314. https://doi.org/10.1073/pnas.070525997 CrossRef

81.

Burns CC, Shaw J, Campagnoli R, Jorba J, Vincent A, Quay J, Kew O (2006) Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. J Virol 80(7):3259–3272. https://doi.org/10.1128/Jvi.80.7.3259-3272.2006 CrossRefPubMedPubMedCentral

82.

Nogales A, Baker SF, Ortiz-Riano E, Dewhurst S, Topham DJ, Martinez-Sobrido L (2014) Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development. J Virol 88(18):10525–10540. https://doi.org/10.1128/Jvi.01565-14 CrossRefPubMedPubMedCentral

83.

Gong XQ, Sun YF, Ruan BY, Liu XM, Wang Q, Yang HM, Wang SY, Zhang P, Wang XH, Shan TL, Tong W, Zhou YJ, Li GX, Zheng H, Tong GZ, Yu H (2017) PA-X protein decreases replication and pathogenicity of swine influenza virus in cultured cells and mouse models. Vet Microbiol 205:66–70. https://doi.org/10.1016/j.vetmic.2017.05.004 CrossRefPubMed

84.

Hu J, Mo YQ, Gao Z, Wang XQ, Gu M, Liang YY, Cheng X, Hu SL, Liu WB, Liu HM, Chen SJ, Liu XW, Peng DX, Liu XF (2016) PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice. Med Microbiol Immun 205(4):381–395. https://doi.org/10.1007/s00430-016-0461-2 CrossRef

85.

Xu G, Zhang X, Sun Y, Liu Q, Sun H, Xiong X, Jiang M, He Q, Wang Y, Pu J, Guo X, Yang H, Liu J (2016) Truncation of C-terminal 20 amino acids in PA-X contributes to adaptation of swine influenza virus in pigs. Sci Rep 6:21845. https://doi.org/10.1038/srep21845 CrossRefPubMedPubMedCentral

86.

Li QH, Yuan XY, Wang Q, Chang GB, Wang F, Liu RR, Zheng MQ, Chen GH, Wen J, Zhao GP (2016) Interactomic landscape of PA-X-chicken protein complexes of H5N1 influenza A virus. J Proteom 148:20–25. https://doi.org/10.1016/j.jprot.2016.07.009 CrossRef

87.

Zhang J, Fu LL, Tian M, Liu HQ, Li JJ, Li Y, He J, Huang J, Ouyang L, Gao HY, Wang JH (2015) Design and synthesis of a novel candidate compound NTI-007 targeting sodium taurocholate cotransporting polypeptide [NTCP]-APOA1-HBx-Beclin1-mediated autophagic pathway in HBV therapy. Bioorgan Med Chem 23(5):976–984. https://doi.org/10.1016/j.bmc.2015.01.020 CrossRef

88.

Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MMC (2002) Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292(2):198–210. https://doi.org/10.1006/viro.2001.1225 CrossRefPubMed

89.

Zheng SQ, Li YX, Zhang Y, Li X, Tang H (2011) MiR-101 regulates HSV-1 replication by targeting ATP5B. Antivir Res 89(3):219–226. https://doi.org/10.1016/j.antiviral.2011.01.008 CrossRefPubMed

90.

Kumar D, Broor S, Rajala MS (2016) Interaction of host nucleolin with influenza A virus nucleoprotein in the early phase of infection limits the late viral gene expression. PLoS One 11(10):e0164146. https://doi.org/10.1371/journal.pone.0164146 CrossRefPubMedPubMedCentral

91.

Murayama R, Harada Y, Shibata T, Kuroda K, Hayakawa S, Shimizu K, Tanaka T (2007) Influenza A virus non-structural protein 1 (NS1) interacts with cellular multifunctional protein nucleolin during infection. Biochem Bioph Res Co 362(4):880–885. https://doi.org/10.1016/j.bbrc.2007.08.091 CrossRef

92.

Melen K, Tynell J, Fagerlund R, Roussel P, Hernandez-Verdun D, Julkunen I (2012) Influenza A H3N2 subtype virus NS1 protein targets into the nucleus and binds primarily via its C-terminal NLS2/NoLS to nucleolin and fibrillarin. Virol J. https://doi.org/10.1186/1743-422x-9-167 CrossRefPubMedPubMedCentral

93.

Chan CM, Chu H, Zhang AJ, Leung LH, Sze KH, Kao RYT, Chik KKH, To KKW, Chan JFW, Chen HL, Jin DY, Liu L, Yuen KY (2016) Hemagglutinin of influenza A virus binds specifically to cell surface nucleolin and plays a role in virus internalization. Virology 494:78–88. https://doi.org/10.1016/j.virol.2016.04.008 CrossRefPubMed

94.

Balinsky CA, Schmeisser H, Ganesan S, Singh K, Pierson TC, Zoon KC (2013) Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles. J Virol 87(24):13094–13106. https://doi.org/10.1128/Jvi.00704-13 CrossRefPubMedPubMedCentral

95.

Bose S, Basu M, Banerjee AK (2004) Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol 78(15):8146–8158. https://doi.org/10.1128/JVI.78.15.8146-8158.2004 CrossRefPubMedPubMedCentral

96.

Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG (2011) Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nature Med 17(9):1132–1135. https://doi.org/10.1038/nm.2444 CrossRefPubMed

97.

Thongtan T, Wikan N, Wintachai P, Rattanarungsan C, Srisomsap C, Cheepsunthorn P, Smith DR Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells. (Electronic)

98.

Xiao X, Feng Y, Zhu Z, Dimitrov DS (2011) Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem Biophys Res Commun 411(2):253–258. https://doi.org/10.1016/j.bbrc.2011.06.109 CrossRefPubMedPubMedCentral

99.

Nisole S, Krust B, Hovanessian AG (2002) Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp Cell Res 276(2):155–173. https://doi.org/10.1006/excr.2002.5522 CrossRefPubMed

100.

Nisole S, Said EA, Mische C, Prevost MC, Krust B, Bouvet P, Bianco A, Briand JP, Hovanessian AG (2002) The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J Biol Chem 277(23):20877–20886. https://doi.org/10.1074/jbc.M110024200 CrossRefPubMed

101.

Gadad SS, Rajan RE, Senapati P, Chatterjee S, Shandilya J, Dash PK, Ranga U, Kundu TK (2011) HIV-1 infection induces acetylation of NPM1 that facilitates tat localization and enhances viral transactivation. J Mol Biol 410(5):997–1007. https://doi.org/10.1016/j.jmb.2011.04.009 CrossRefPubMed

102.

Lu JW, Chang JG, Yeh KT, Chen RM, Tsai JJP, Hu RM (2011) Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochem 113(8):833–838. https://doi.org/10.1016/j.acthis.2011.01.001 CrossRefPubMed

103.

Irie T, Inoue M, Sakaguchi T (2010) Significance of the YLDL motif in the M protein and Alix/AIP1 for Sendai virus budding in the context of virus infection. Virology 405(2):334–341. https://doi.org/10.1016/j.virol.2010.06.031 CrossRefPubMed

104.

Su S, Bi YH, Wong G, Gray GC, Gao GF, Li SJ (2015) Epidemiology, evolution, and recent outbreaks of avian influenza virus in China. J Virol 89(17):8671–8676. https://doi.org/10.1128/Jvi.01034-15 CrossRefPubMedPubMedCentral

105.

Shi WF, Li W, Li XB, Haywood J, Ma JC, Gao GF, Liu D (2014) Phylogenetics of varied subtypes of avian influenza viruses in China: potential threat to humans. Protein Cell 5(4):253–257. https://doi.org/10.1007/s13238-014-0036-1 CrossRefPubMedPubMedCentral

106.

Wang XL, Jiang H, Wu P, Uyeki TM, Feng LZ, Lai SJ, Wang LL, Huo X, Xu K, Chen EF, Wang XX, He JF, Kang M, Zhang RL, Zhang J, Wu JB, Hu SX, Zhang HJ, Liu XQ, Fu WJ, Ou JM, Wu SG, Qin Y, Zhang ZJ, Shi YJ, Zhang JJ, Artois J, Fang VJ, Zhu HC, Guan Y, Gilbert M, Horby PW, Leung GM, Gao GF, Cowling BJ, Yu HJ (2017) Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis 17(8):822–832. https://doi.org/10.1016/S1473-3099(17)30323-7 CrossRefPubMedPubMedCentral

107.

Durand LO, Glew P, Gross D, Kasper M, Trock S, Kim IK, Bresee JS, Donis R, Uyeki TM, Widdowson MA, Azziz-Baumgartner E (2015) Timing of influenza A(H5N1) in poultry and humans and seasonal influenza activity worldwide, 2004–2013. Emerg Infect Dis 21(2):202–208. https://doi.org/10.3201/eid2102.140877 CrossRefPubMedPubMedCentral

108.

Pan M, Gao RB, Lv Q, Huang SH, Zhou ZH, Yang L, Li XD, Zhao X, Zou XH, Tong WB, Mao SL, Zou SM, Bo H, Zhu XP, Liu L, Yuan H, Zhang MH, Wang DQ, Li ZM, Zhao W, Ma ML, Li YQ, Li TS, Yang HP, Xu JN, Zhou LJ, Zhou XY, Tang W, Song Y, Chen T, Bai T, Zhou JF, Wang DY, Wu GZ, Li DX, Feng ZJ, Gao GF, Wang Y, He SS, Shu YL (2016) Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect 72(1):52–59. https://doi.org/10.1016/j.jinf.2015.06.009 CrossRefPubMed

109.

Bi YH, Chen QJ, Wang QL, Chen JJ, Jin T, Wong G, Quan CS, Liu J, Wu J, Yin RF, Zhao LH, Li MX, Ding Z, Zou RR, Xu W, Li H, Wang HJ, Tian KG, Fu GH, Huang Y, Shestopalov A, Li SJ, Xu B, Yu HJ, Luo TR, Lu L, Xu X, Luo Y, Liu YX, Shi WF, Liu D, Gao GF (2016) Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe 20(6):810–821. https://doi.org/10.1016/j.chom.2016.10.022 CrossRefPubMed

110.

Zhang Y, Chen MM, Huang YW, Zhu WF, Yang L, Gao LD, Li XD, Bi FY, Huang CY, Kang N, Zhang HJ, Li Z, Bo H, Wang DY, Shu YL (2017) Human infections with novel reassortant H5N6 avian influenza viruses in China. Emerg Microbes Infec. https://doi.org/10.1038/emi.2017.38 CrossRef

111.

Peiris M, Yuen KY, Leung CW, Chan KH, Ip PLS, Lai RWM, Orr WK, Shortridge KF (1999) Human infection with influenza H9N2. Lancet 354(9182):916–917. https://doi.org/10.1016/S0140-6736(99)03311-5 CrossRefPubMed

112.

Yuan RY, Liang LJ, Wu J, Kang YF, Song YC, Zou LR, Zhang X, Ni HZ, Ke CW (2017) Human infection with an avian influenza A/H9N2 virus in Guangdong in 2016. J Infection 74(4):422–425. https://doi.org/10.1016/j.jinf.2017.01.003 CrossRef

Title: PA-X: a key regulator of influenza A virus pathogenicity and host immune responses
Authors: Jiao Hu
Chunxi Ma
Xiufan Liu
Publication date: 01-11-2018
Publisher: Springer Berlin Heidelberg
Published in: Medical Microbiology and Immunology / Issue 5-6/2018
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-018-0548-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5-6/2018

A clone of the emergent Streptococcus pyogenes emm89 clade responsible for a large outbreak in a post-surgery oncology unit in France

Preventing vertical virus infections: the role of serologic screening of pregnant women

Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein

The interplay between local immune response and Epstein–Barr virus-infected tonsillar cells could lead to viral infection control

Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus

Lopinavir serum concentrations of critically ill infants: a pharmacokinetic investigation in South Africa

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage